Cancer Genomics
- Cancer PHGKB -
What's New
Last Posted: Mar 27, 2019
- Resolving genetic heterogeneity in cancer
S Turajlic et al, Nature Rev Genetics, March 27, 2019 - Should women with a BRCA1/2 mutation aged 60 and older be offered intensified breast cancer screening? - A cost-effectiveness analysis.
Phi Xuan-Anh et al. Breast (Edinburgh, Scotland) 2019 Mar 4582-88 - Total abdominal colectomy is cost-effective in treating colorectal cancer in patients with genetically diagnosed Lynch Syndrome.
Jiang Boxiang et al. American journal of surgery 2019 Mar - A response to "Personalised medicine and population health: breast and ovarian cancer".
Antoniou Antonis et al. Human genetics 2019 Mar 138(3) 287-289 - A systematic literature review of machine learning in online personal health data.
Yin Zhijun et al. Journal of the American Medical Informatics Association : JAMIA 2019 Mar - Author response to "a response to 'personalised medicine and population health: breast and ovarian cancer'".
Narod Steven A et al. Human genetics 2019 Mar 138(3) 291-292 - Cancer Treatment in the Genomic Era.
Doherty Gary J et al. Annual review of biochemistry 2019 Mar - Clinical usefulness of gastric adenocarcinoma predictive long intergenic noncoding RNA in human malignancies: A meta-analysis.
Liu Wanwei et al. Pathology, research and practice 2019 Mar - Enhanced Patient Activation in Cancer Care Transitions: Protocol for a Randomized Controlled Trial of a Tailored Electronic Health Intervention for Men With Prostate Cancer.
Ekstedt Mirjam et al. JMIR research protocols 2019 Mar 8(3) e11625 - Evaluation of Machine-Learning Algorithms for Predicting Opioid Overdose Risk Among Medicare Beneficiaries With Opioid Prescriptions.
Lo-Ciganic Wei-Hsuan et al. JAMA network open 2019 Mar 2(3) e190968 - Hope and challenge: Precision medicine in bladder cancer.
Su Hongwei et al. Cancer medicine 2019 Mar - Machine learning in medicine: a practical introduction.
Sidey-Gibbons Jenni A M et al. BMC medical research methodology 2019 Mar 19(1) 64 - Potential Utility of Liquid Biopsy as a Diagnostic and Prognostic Tool for the Assessment of Solid Tumors: Implications in the Precision Oncology.
Mathai Roshni Ann et al. Journal of clinical medicine 2019 Mar 8(3) - Using clinical genomic sequencing to guide personalized cancer therapy in China.
Bai Yuxian et al. Personalized medicine 2019 Mar - Are genetic tests useful to predict cancer?
H Devlin, The Guardian, March 23, 2019
No hay comentarios:
Publicar un comentario